Patent claims reciting compounds where at least one group of a compound genus is defined by its function are common. For example, familiar claim terms such as “chelating moiety,” “linker,” and “binding moiety” describe a...more
6/6/2025
/ Amgen v Sanofi ,
Enablement Inquiries ,
Functional Claim Language ,
Intellectual Property Protection ,
Patent Applications ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Post-Grant Review ,
Section 112 ,
USPTO ,
Written Descriptions